Stay updated on Phase 3 Daclatasvir/Asunaprevir in Hepatitis C Clinical Trial

Sign up to get notified when there's something new on the Phase 3 Daclatasvir/Asunaprevir in Hepatitis C Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Phase 3 Daclatasvir/Asunaprevir in Hepatitis C Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    2 days ago
    No Change Detected
  3. Check
    3 days ago
    No Change Detected
  4. Check
    4 days ago
    Change Detected
    Summary
    The study has expanded to include 29 locations, and the revision has been updated from v2.9.7 to v2.10.0.
    Difference
    0.5%
    Check dated 2024-07-23T15:10:43.000Z thumbnail image
  5. Check
    5 days ago
    Change Detected
    Summary
    A new Investigator Inquiry form has been added to the website.
    Difference
    0.2%
    Check dated 2024-07-22T13:51:53.000Z thumbnail image
  6. Check
    11 days ago
    Change Detected
    Summary
    The website has been updated to Revision v2.9.7 from v2.9.6.
    Difference
    0.1%
    Check dated 2024-07-16T08:35:45.000Z thumbnail image
  7. Check
    25 days ago
    Change Detected
    Summary
    The value of Revision has been updated from v2.9.5 to v2.9.6, indicating a recent revision in the content of the webpage.
    Difference
    0.1%
    Check dated 2024-07-02T14:48:26.000Z thumbnail image
  8. Check
    28 days ago
    Change Detected
    Summary
    The value on the web page has recently changed to FDA Safety Alerts and Recalls, indicating a shift in the content focus towards safety alerts and recalls issued by the FDA.
    Difference
    0.3%
    Check dated 2024-06-29T12:45:38.000Z thumbnail image
  9. Check
    30 days ago
    Change Detected
    Summary
    The value of Revision has been updated from v2.9.3 to v2.9.5, indicating a recent revision in the content of the webpage.
    Difference
    0.1%
    Check dated 2024-06-27T10:52:33.000Z thumbnail image

Stay in the know with updates to Phase 3 Daclatasvir/Asunaprevir in Hepatitis C Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Phase 3 Daclatasvir/Asunaprevir in Hepatitis C Clinical Trial page.